Marsha Alpert Chandler, a director of Biocept, recently acquired 4,545 shares of the company. The buys took place at prices ranging from $0.00 to $1.10 per share, on dates ranging from March 04 to October 19, 2016. Chandler now owns 6,905 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Chandler operates out of San Diego, CA. Some additional info was provided as follows:

On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,333 fewer shares with respect to these shares. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 3,385 fewer shares with respect to thes e shares. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept Announces Pricing Of Public Offering Of Up To 4,925,936 Shares Of Common Stock - Dec. 6, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 6, 2017
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Dec. 6, 2017
General form for registration of securities under the Securities Act of 1933 - Nov. 21, 2017

Auto Refresh

Feedback